- Because many skin diseases are characterized by disruption of keratinocyte proliferation and differentiation, it is important to understand the mechanisms underlying these processes. While external regulators that activate intracellular signaling pathways are clearly important, these ultimately regulate gene expression by controlling the activity of transcription factors that bind to gene-regulatory regions. POU domain factors, which act by binding to octamer DNA sites, have been shown to be important in terminal differentiation in several organ system. Three such genes Oct1, Tst1, and epidermal specific Skn1 are highly expressed in epidermis. Octamer sites have been found in regulatory regions of several epidermal-specific genes. Indeed, the applicants' studies with Skn1 and Tst1 gene-deleted mice have suggested that the Skn1 gene acts as a repressor of wound front keratinocyte differentiation and that it collaborates with Tst1 to promote normal differentiation of keratinocytes. However, in contrast to mutations of other tissue-specific POU domain genes, no block in differentiation is observed in the Skn1 gene-deleted mice. This likely reflects a functional redundancy between Skn1 and the homologous Oct1 factor that has an identical DNA binding preference. The long-term objective is to understand the role of octamer-binding proteins in epidermal development and function. This is likely to provide insights into regulatory systems in which highly related transcription factors binding to the same DNA sites are co-expressed.
The specific aims are to: 1) Determine the role of Oct-1 in epidermal development and homeostasis, using conditional gene knockout technology; 2) elucidate the mechanisms underlying regulation of keratinocyte differentiation in wound healing by Skn1, using existing gene-deleted mice and novel transgenic mice; 3) identify co-regulators for Skn1a and Skn-1i in epidermis, using a yeast one-hybrid system.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR044882-03
Application #
6171764
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Moshell, Alan N
Project Start
1998-08-01
Project End
2001-02-28
Budget Start
2000-08-01
Budget End
2001-02-28
Support Year
3
Fiscal Year
2000
Total Cost
$22,686
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Plikus, Maksim V; Andersen, Bogi (2018) Skin as a window to body-clock time. Proc Natl Acad Sci U S A 115:12095-12097
Klein, Rachel Herndon; Hu, William; Kashgari, Ghaidaa et al. (2017) Characterization of enhancers and the role of the transcription factor KLF7 in regulating corneal epithelial differentiation. J Biol Chem 292:18937-18950
Klein, Rachel Herndon; Stephens, Denise N; Ho, Hsiang et al. (2016) Cofactors of LIM Domains Associate with Estrogen Receptor ? to Regulate the Expression of Noncoding RNA H19 and Corneal Epithelial Progenitor Cell Function. J Biol Chem 291:13271-85
Spitler, Ryan; Ho, Hsiang; Norpetlian, Frederique et al. (2015) Combination of low level light therapy and nitrosyl-cobinamide accelerates wound healing. J Biomed Opt 20:051022
Gordon, William M; Zeller, Michael D; Klein, Rachel H et al. (2014) A GRHL3-regulated repair pathway suppresses immune-mediated epidermal hyperplasia. J Clin Invest 124:5205-18
Watanabe, Kazuhide; Biesinger, Jacob; Salmans, Michael L et al. (2014) Integrative ChIP-seq/microarray analysis identifies a CTNNB1 target signature enriched in intestinal stem cells and colon cancer. PLoS One 9:e92317
Salmans, Michael L; Yu, Zhengquan; Watanabe, Kazuhide et al. (2014) The co-factor of LIM domains (CLIM/LDB/NLI) maintains basal mammary epithelial stem cells and promotes breast tumorigenesis. PLoS Genet 10:e1004520
Peyrard-Janvid, Myriam; Leslie, Elizabeth J; Kousa, Youssef A et al. (2014) Dominant mutations in GRHL3 cause Van der Woude Syndrome and disrupt oral periderm development. Am J Hum Genet 94:23-32
Watanabe, Kazuhide; Villarreal-Ponce, Alvaro; Sun, Peng et al. (2014) Mammary morphogenesis and regeneration require the inhibition of EMT at terminal end buds by Ovol2 transcriptional repressor. Dev Cell 29:59-74
Bhandari, A; Gordon, W; Dizon, D et al. (2013) The Grainyhead transcription factor Grhl3/Get1 suppresses miR-21 expression and tumorigenesis in skin: modulation of the miR-21 target MSH2 by RNA-binding protein DND1. Oncogene 32:1497-507

Showing the most recent 10 out of 40 publications